Anderson CP, et al. Synergism of buthionine sulfoximine and melphalan against neuroblastoma cell lines derived after disease progression. Med Pediatr Oncol 2000 Dec 1;35(6):659-662
[Related articles] |
Choi LM, et al. Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma. Med Pediatr Oncol 2000 Dec 1;35(6):647-650
[Related articles] |
Coffey DC, et al. Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro. Med Pediatr Oncol 2000 Dec 1;35(6):577-581
[Related articles] |
Cunningham S, et al. A gene therapy approach to enhance the targeted radiotherapy of neuroblastoma. Med Pediatr Oncol 2000 Dec 1;35(6):708-711
[Related articles] |
Davidoff AM, et al. Retroviral vector-producer cell mediated angiogenesis inhibition restricts neuroblastoma growth in vivo. Med Pediatr Oncol 2000 Dec 1;35(6):638-640
[Related articles] |
Eggert A, et al. Different effects of TrkA expression in neuroblastoma cell lines with or without MYCN amplification. Med Pediatr Oncol 2000 Dec 1;35(6):623-627
[Related articles] MYCN Amplification
|
Eggert A, et al. Resistance to TRAIL-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Med Pediatr Oncol 2000 Dec 1;35(6):603-607
[Related articles] |
Eggert A, et al. p75 mediated apoptosis in neuroblastoma cells is inhibited by expression of TrkA. Med Pediatr Oncol 2000 Dec 1;35(6):573-576
[Related articles] |
Eggert A, et al. Expression of neurotrophin receptor TrkA inhibits angiogenesis in neuroblastoma. Med Pediatr Oncol 2000 Dec 1;35(6):569-572
[Related articles] |
Fulda S, et al. Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors. Med Pediatr Oncol 2000 Dec 1;35(6):616-618
[Related articles] |
Fulda S, et al. MycN sensitizes neuroblastoma cells for drug-triggered apoptosis. Med Pediatr Oncol 2000 Dec 1;35(6):582-584
[Related articles] MYCN Amplification
|
Furuta S, et al. Analysis of loss of heterozygosity at 16p12-p13 (familial neuroblastoma locus) in 470 neuroblastomas including both sporadic and mass screening tumors. Med Pediatr Oncol 2000 Dec 1;35(6):531-533
[Related articles] Screening
|
Gilbert JA, et al. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells. Clin Cancer Res 2000 Nov;6(11):4365-72
[Related articles] |
Goto H, et al. Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors. Med Pediatr Oncol 2000 Dec 1;35(6):619-622
[Related articles] |
Hogarty MD, et al. BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification. Med Pediatr Oncol 2000 Dec 1;35(6):559-562
[Related articles] MYCN Amplification
|
Hogarty MD, et al. Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas. Med Pediatr Oncol 2000 Dec 1;35(6):512-515
[Related articles] Chromosome 1p
|
Hopkins-Donaldson S, et al. Loss of caspase-8 expression in neuroblastoma is related to malignancy and resistance to TRAIL-induced apoptosis. Med Pediatr Oncol 2000 Dec 1;35(6):608-611
[Related articles] |
Hoshi M, et al. Deletion mapping of 14q32 in human neuroblastoma defines an 1,100-kb region of common allelic loss. Med Pediatr Oncol 2000 Dec 1;35(6):522-525
[Related articles] |
Huang D, et al. Schwann cell-conditioned medium inhibits angiogenesis in vitro and in vivo. Med Pediatr Oncol 2000 Dec 1;35(6):590-592
[Related articles] |
Islam A, et al. Role of survivin, whose gene is mapped to 17q25, in human neuroblastoma and identification of a novel dominant-negative isoform, survivin-beta/2B. Med Pediatr Oncol 2000 Dec 1;35(6):550-553
[Related articles] Chromosome 17q
|
Jorgensen GE, et al. Human polyomavirus BK (BKV) and neuroblastoma: Mechanisms of oncogenic action and possible strategy for novel treatment. Med Pediatr Oncol 2000 Dec 1;35(6):593-596
[Related articles] |
Kanai M, et al. A model of bacterial translocation in neuroblastoma-bearing mice. J Pediatr Surg 2000 Dec;35(12):1701-1705
[Related articles] |
Kawamoto T, et al. Association between favorable neuroblastoma and high expression of the novel metalloproteinase gene, nbla3145/XCE, cloned by differential screening of the full-length-enriched oligo-capping neuroblastoma cDNA l Med Pediatr Oncol 2000 Dec 1;35(6):628-631
[Related articles] Screening
|
Keshelava N, et al. p53 mutations and loss of p53 function confer multidrug resistance in neuroblastoma. Med Pediatr Oncol 2000 Dec 1;35(6):563-568
[Related articles] |
Lode HN, et al. Tyrosine hydroxylase-based DNA-vaccination is effective against murine neuroblastoma. Med Pediatr Oncol 2000 Dec 1;35(6):641-646
[Related articles] |
Lovat PE, et al. Distinct properties of fenretinide and CD437 lead to synergistic responses with chemotherapeutic reagents. Med Pediatr Oncol 2000 Dec 1;35(6):663-668
[Related articles] |
Maurer BJ, et al. Synergistic Cytotoxicity in Solid Tumor Cell Lines Between N-(4-Hydroxyphenyl)retinamide and Modulators of Ceramide Metabolism. J Natl Cancer Inst 2000 Dec 6;92(23):1897-1909
[Related articles] |
Mora J, et al. Laser-capture microdissected Schwannian and neuroblastic cells in stage 4 neuroblastomas have the same genetic alterations. Med Pediatr Oncol 2000 Dec 1;35(6):534-537
[Related articles] |
Nakagawara A, et al. Identification of the homozygously deleted region at chromosome 1p36.2 in human neuroblastoma. Med Pediatr Oncol 2000 Dec 1;35(6):516-521
[Related articles] Chromosome 1p
|
Norris MD, et al. Expression of N-myc and MRP genes and their relationship to N-myc gene dosage and tumor formation in a murine neuroblastoma model. Med Pediatr Oncol 2000 Dec 1;35(6):585-589
[Related articles] MYCN Amplification
|
O'Neill S, et al. MYCN amplification and 17q in neuroblastoma: Evidence for structural association. Genes Chromosomes Cancer 2001 Jan;30(1):87-90
[Related articles] MYCN Amplification Chromosome 17q
|
Ohira M, et al. Hunting the subset-specific genes of neuroblastoma: Expression profiling and differential screening of the full-length-enriched oligo-capping cDNA libraries. Med Pediatr Oncol 2000 Dec 1;35(6):547-549
[Related articles] Screening
|
Poremba C, et al. Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas. Med Pediatr Oncol 2000 Dec 1;35(6):651-655
[Related articles] |
Reynolds CP, et al. Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide. Med Pediatr Oncol 2000 Dec 1;35(6):597-602
[Related articles] |